Search Results - "Carlin, Nils"
-
1
Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice
Published in Vaccine (08-11-2011)“…Abstract Coli surface antigen 6 (CS6) is one of the most prevalent non-fimbrial colonization factors (CFs) of enterotoxigenic Escherichia coli (ETEC) bacteria,…”
Get full text
Journal Article -
2
A Novel Glucosyltransferase Involved in O-Antigen Modification of Shigella flexneri Serotype 1c
Published in Journal of Bacteriology (01-11-2009)“…Article Usage Stats Services JB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
3
Preparation and preclinical evaluation of a freeze-dried formulation of a novel combined multivalent whole-cell/B-subunit oral vaccine against enterotoxigenic Escherichia coli diarrhea
Published in European journal of pharmaceutics and biopharmaceutics (01-11-2016)“…[Display omitted] A promising liquid killed multivalent whole-cell plus enterotoxin B-subunit oral vaccine against enterotoxigenic Escherichia coli (ETEC), the…”
Get full text
Journal Article -
4
Shigella flexneri serotype 1c derived from serotype 1a by acquisition of gtrIC gene cluster via a bacteriophage
Published in BMC microbiology (27-06-2016)“…Shigella spp. are the primary causative agents of bacillary dysentery. Since its emergence in the late 1980s, the S. flexneri serotype 1c remains poorly…”
Get full text
Journal Article -
5
A Perspective on the Strategy for Advancing ETVAX ® , An Anti-ETEC Diarrheal Disease Vaccine, into a Field Efficacy Trial in Gambian Children: Rationale, Challenges, Lessons Learned, and Future Directions
Published in Microorganisms (Basel) (01-01-2024)“…For the first time in over 20 years, an Enterotoxigenic (ETEC) vaccine candidate, ETVAX , has advanced into a phase 2b field efficacy trial for children 6-18…”
Get full text
Journal Article -
6
Efficacy of an Enterotoxigenic Escherichia coli (ETEC) Vaccine on the Incidence and Severity of Traveler's Diarrhea (TD): Evaluation of Alternative Endpoints and a TD Severity Score
Published in Microorganisms (Basel) (27-09-2023)“…The efficacy of an Oral Whole Cell ETEC Vaccine (OEV) against Travelers' Diarrhea (TD) was reexamined using novel outcome and immunologic measures. More…”
Get full text
Journal Article -
7
The nptA Gene of Vibrio cholerae Encodes a Functional Sodium-Dependent Phosphate Cotransporter Homologous to the Type II Cotransporters of Eukaryotes
Published in Journal of Bacteriology (01-08-2002)“…Article Usage Stats Services JB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
8
Cross-reactivity and avidity of antibody responses induced in humans by the oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine ETVAX
Published in Vaccine (13-07-2017)“…Highlights • ETVAX induces cross-reactive antibodies that bind to related, non-vaccine colonisation factors. • ETVAX may protect against a wider range of ETEC…”
Get full text
Journal Article -
9
Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study
Published in Vaccine (12-12-2014)“…Highlights • We have tested a new oral killed ETEC vaccine ± dmLT adjuvant in Swedish adults. • The vaccine contained E. coli bacteria overexpressing common…”
Get full text
Journal Article -
10
Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial
Published in The Lancet infectious diseases (01-02-2020)“…Enterotoxigenic Escherichia coli causes diarrhoea, leading to substantial mortality and morbidity in children, but no specific vaccine exists. This trial…”
Get full text
Journal Article -
11
The Tailspike Protein of Shigella Phage Sf6
Published in The Journal of biological chemistry (17-01-2003)“…Bacteriophage Sf6 tailspike protein is functionally equivalent to the well characterized tailspike ofSalmonella phage P22, mediating attachment of the viral…”
Get full text
Journal Article -
12
Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses
Published in Vaccine (03-09-2019)“…Highlights•The killed oral ETEC vaccine ETVAX ± dmLT adjuvant was safe in Bangladeshi adults. •All vaccinees responded to all 5 primary vaccine antigens in ALS…”
Get full text
Journal Article -
13
Identification of Shigella flexneri subserotype 1c in rural Egypt
Published in Journal of clinical microbiology (01-03-1999)“…In a population-based study of diarrhea in rural, northern Egypt, 60 Shigella flexneri strains were identified, of which 10 could not be definitively…”
Get full text
Journal Article -
14
Safety, tolerability, and immunogenicity of an oral inactivated ETEC vaccine (ETVAX®) with dmLT adjuvant in healthy adults and children in Zambia: An age descending randomised, placebo-controlled trial
Published in Vaccine (02-11-2023)“…Enterotoxigenic Escherichia coli (ETEC) is an important cause of moderate to severe diarrhoea in children for which there is no licensed vaccine. We evaluated…”
Get full text
Journal Article -
15
Cross-reactivity and avidity of antibody responses induced in humans by the oral inactivated multivalent enterotoxigenicEscherichia coli (ETEC) vaccine ETVAX
Published in Vaccine (13-07-2017)“…•ETVAX induces cross-reactive antibodies that bind to related, non-vaccine colonisation factors.•ETVAX may protect against a wider range of ETEC strains than…”
Get full text
Journal Article -
16
Safety and immunogenicity of ETVAX®, an oral inactivated vaccine against enterotoxigenic Escherichia coli diarrhoea: a double-blinded, randomized, placebo-controlled trial amongst Finnish travellers to Benin, West Africa
Published in Journal of travel medicine (18-11-2023)“…Abstract Background No licensed human vaccines are available against enterotoxigenic Escherichia coli (ETEC), a major diarrhoeal pathogen affecting children in…”
Get full text
Journal Article -
17
Efficacy of an Enterotoxigenic IEscherichia coli/I : Evaluation of Alternative Endpoints and a TD Severity Score
Published in Microorganisms (Basel) (01-09-2023)“…The efficacy of an Oral Whole Cell ETEC Vaccine (OEV) against Travelers’ Diarrhea (TD) was reexamined using novel outcome and immunologic measures. More…”
Get full text
Journal Article -
18
Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenicEscherichia coli(ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study
Published in Vaccine (12-12-2014)“…Background We have developed a new oral vaccine against enterotoxigenicEscherichia coli(ETEC), which is the most common cause of bacterial diarrhea in children…”
Get full text
Journal Article -
19
Construction of a non-toxigenicEscherichia colioral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice
Published in Vaccine (08-11-2011)“…Coli surface antigen 6 (CS6) is one of the most prevalent non-fimbrial colonization factors (CFs) of enterotoxigenicEscherichia coli(ETEC) bacteria, which are…”
Get full text
Journal Article -
20
Structural studies of the O-antigenic polysaccharide of Escherichia coli O86, which possesses blood-group B activity
Published in Carbohydrate research (01-02-1989)“…The O-specific side-chains of the lipopolysaccharide from Escherichia coli O86:K2:H2 have been investigated using n.m.r. spectroscopy, methylation analysis,…”
Get more information
Journal Article